| Literature DB >> 25896511 |
Tobias Goldmann1, Nicolas Zeller1, Jenni Raasch1, Katrin Kierdorf1, Kathrin Frenzel1, Lars Ketscher1, Anja Basters1, Ori Staszewski1, Stefanie M Brendecke1, Alena Spiess1, Tuan Leng Tay1, Clemens Kreutz2, Jens Timmer3, Grazia M S Mancini4, Thomas Blank1, Günter Fritz1, Knut Biber5, Roland Lang6, Danielle Malo7, Doron Merkler8, Mathias Heikenwälder9, Klaus-Peter Knobeloch1, Marco Prinz10.
Abstract
Microglia are tissue macrophages of the central nervous system (CNS) that control tissue homeostasis. Microglia dysregulation is thought to be causal for a group of neuropsychiatric, neurodegenerative and neuroinflammatory diseases, called "microgliopathies". However, how the intracellular stimulation machinery in microglia is controlled is poorly understood. Here, we identified the ubiquitin-specific protease (Usp) 18 in white matter microglia that essentially contributes to microglial quiescence. We further found that microglial Usp18 negatively regulates the activation of Stat1 and concomitant induction of interferon-induced genes, thereby terminating IFN signaling. The Usp18-mediated control was independent from its catalytic activity but instead required the interaction with Ifnar2. Additionally, the absence of Ifnar1 restored microglial activation, indicating a tonic IFN signal which needs to be negatively controlled by Usp18 under non-diseased conditions. These results identify Usp18 as a critical negative regulator of microglia activation and demonstrate a protective role of Usp18 for microglia function by regulating the Ifnar pathway. The findings establish Usp18 as a new molecule preventing destructive microgliopathy.Entities:
Keywords: EAE; Usp18; microglia; multiple sclerosis; type I interferon
Mesh:
Substances:
Year: 2015 PMID: 25896511 PMCID: PMC4475397 DOI: 10.15252/embj.201490791
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598